- Home
- CYTK vs HIMS Comparison
CYTK vs HIMS Comparison
Compare CYTK & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- HIMS
- Stock Information
- Founded
- CYTK 1997
- HIMS 2017
- Country
- CYTK United States
- HIMS United States
- Employees
- CYTK N/A
- HIMS N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- HIMS Medical/Nursing Services
- Sector
- CYTK Health Care
- HIMS Health Care
- Exchange
- CYTK Nasdaq
- HIMS Nasdaq
- Market Cap
- CYTK 5.6B
- HIMS 6.0B
- IPO Year
- CYTK 2004
- HIMS N/A
- Fundamental
- Price
- CYTK $32.43
- HIMS $64.22
- Analyst Decision
- CYTK Buy
- HIMS Hold
- Analyst Count
- CYTK 14
- HIMS 12
- Target Price
- CYTK $70.92
- HIMS $38.00
- AVG Volume (30 Days)
- CYTK 1.3M
- HIMS 38.8M
- Earning Date
- CYTK 08-07-2025
- HIMS 08-04-2025
- Dividend Yield
- CYTK N/A
- HIMS N/A
- EPS Growth
- CYTK N/A
- HIMS N/A
- EPS
- CYTK N/A
- HIMS 0.68
- Revenue
- CYTK $19,218,000.00
- HIMS $1,784,353,000.00
- Revenue This Year
- CYTK $18.02
- HIMS $62.41
- Revenue Next Year
- CYTK $737.32
- HIMS $19.85
- P/E Ratio
- CYTK N/A
- HIMS $94.57
- Revenue Growth
- CYTK 412.21
- HIMS 85.99
- 52 Week Low
- CYTK $29.31
- HIMS $13.47
- 52 Week High
- CYTK $61.38
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- CYTK 46.32
- HIMS 66.71
- Support Level
- CYTK $32.02
- HIMS $54.67
- Resistance Level
- CYTK $34.72
- HIMS $61.67
- Average True Range (ATR)
- CYTK 1.30
- HIMS 4.74
- MACD
- CYTK 0.26
- HIMS 0.14
- Stochastic Oscillator
- CYTK 45.08
- HIMS 79.70
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.